172 related articles for article (PubMed ID: 28804825)
1. Assessment of Hereditary Thrombophilia: Performance of Protein C (PC) Testing.
Marlar RA; Gausman JN
Methods Mol Biol; 2017; 1646():145-151. PubMed ID: 28804825
[TBL] [Abstract][Full Text] [Related]
2. Performance of Chromogenic Protein C (PC) Testing.
Adams R; Coleman R; Stanton T
Methods Mol Biol; 2023; 2663():225-232. PubMed ID: 37204713
[TBL] [Abstract][Full Text] [Related]
3. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
[TBL] [Abstract][Full Text] [Related]
4. Protein C.
Hepner M; Karlaftis V
Methods Mol Biol; 2013; 992():365-72. PubMed ID: 23546729
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Hereditary Thrombophilia: Performance of Antithrombin (AT) Testing.
Gausman JN; Marlar RA
Methods Mol Biol; 2017; 1646():161-167. PubMed ID: 28804827
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of the ProC global assay for protein C pathway abnormalities. clinical experience in 899 unselected patients with venous thromboembolism.
Toulon P; Adda R; Perez P
Thromb Res; 2001 Oct; 104(2):93-103. PubMed ID: 11672753
[TBL] [Abstract][Full Text] [Related]
7. Edoxaban: Impact on routine and specific coagulation assays. A practical laboratory guide.
Douxfils J; Chatelain B; Chatelain C; Dogné JM; Mullier F
Thromb Haemost; 2016 Jan; 115(2):368-81. PubMed ID: 26510969
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Hereditary Thrombophilia: Performance of Protein S (PS) Testing.
Marlar RA; Gausman JN
Methods Mol Biol; 2017; 1646():153-160. PubMed ID: 28804826
[TBL] [Abstract][Full Text] [Related]
9. Laboratory tests for protein C deficiency.
Khor B; Van Cott EM
Am J Hematol; 2010 Jun; 85(6):440-2. PubMed ID: 20309856
[TBL] [Abstract][Full Text] [Related]
10. Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.
Tripodi A
Thromb Haemost; 2017 May; 117(5):830-836. PubMed ID: 28229158
[TBL] [Abstract][Full Text] [Related]
11. Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH.
Cooper PC; Pavlova A; Moore GW; Hickey KP; Marlar RA
J Thromb Haemost; 2020 Feb; 18(2):271-277. PubMed ID: 31999059
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo effects of low-dose rivaroxaban on specific coagulation assays and coagulation factor activities in patients under real life conditions.
Mani H; Hesse C; Stratmann G; Lindhoff-Last E
Thromb Haemost; 2013 Jan; 109(1):127-36. PubMed ID: 23138190
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
Johnstone IB; Martin CA
Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
[TBL] [Abstract][Full Text] [Related]
14. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
Dahlbäck B; Carlsson M; Svensson PJ
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1004-8. PubMed ID: 8430067
[TBL] [Abstract][Full Text] [Related]
15. Use of a centrifugal analyzer for a chromogenic prothrombin time, a chromogenic activated partial thromboplastin time and a kinetic fibrinogen assay in a routine hospital laboratory.
de Metz M; van Wersch JW
Haemostasis; 1987; 17(5):254-9. PubMed ID: 3666583
[TBL] [Abstract][Full Text] [Related]
16. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
Favaloro EJ; Mirochnik O; McDonald D
Br J Biomed Sci; 1999; 56(1):23-33. PubMed ID: 10492912
[TBL] [Abstract][Full Text] [Related]
17. Thromboplastin-thrombomodulin-mediated time: a new global test sensitive to protein S deficiency and increased levels of factors II, V, VII and X.
Borrell M; Llobet D; Ortín R; Felices R; Vallvé C; Mateo J; Souto J; Fontcuberta J
Haematologica; 2002 Apr; 87(4):415-9. PubMed ID: 11940486
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis of thrombophilia based on coagulation and genetic studies].
Bałszan-Kowalska I
Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
[TBL] [Abstract][Full Text] [Related]
19. Danger of false negative (exclusion) or false positive (diagnosis) for 'congenital thrombophilia' in the age of anticoagulants.
Favaloro EJ
Clin Chem Lab Med; 2019 May; 57(6):873-882. PubMed ID: 30485173
[TBL] [Abstract][Full Text] [Related]
20. Thrombophilia and venous thromboembolism: implications for testing.
Cohn DM; Roshani S; Middeldorp S
Semin Thromb Hemost; 2007 Sep; 33(6):573-81. PubMed ID: 17768689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
